Establishment LabsvsMerck & Company

ESTA and MRK stock compared: price, dividend, valuation and results, from SEC filings.

ESTA

Establishment Labs Holdings Inc.

$69.61

Value $2.0B

-1.68%
ESTA's page

MRK

Merck & Company, Inc.

$132.81

Value $328B

-3.61%
MRK's page

Establishment Labs (ESTA) has a market value of $2.0B and Merck & Company (MRK) $328B. Over the last year, with dividends, ESTA moved +7.8% and MRK +41.8%. Dividend yield: ESTA none, MRK 2.56%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ESTA$2.0B

    MRK$328B

    MRK is 161 times ESTA

  • Revenue, 12 months

    ESTA$264M

    MRK$67.4B

    MRK is 255 times ESTA

  • Net income, 12 months

    ESTA-$38M

    MRK$2.5B

  • Operating margin

    ESTA-6.6%

    MRK–

  • ROIC

    ESTA-5.0%

    MRK3.9%

    8.9 points apart

  • P/E

    ESTA–

    MRK133.9

  • Dividend yield

    ESTA0.0%

    MRK2.6%

    2.6 points apart

  • 5-year return

    ESTA+8.7%

    MRK+86.3%

    77.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ESTA+8.7%

MRK+86.3%

10020020222023202420252026
Returns by period
PeriodESTAWith dividendsMRKWith dividends
1 year since November 18, 2025+7.8%Price +7.8%+41.8%Price +37.7%
3 years since November 17, 2023+216.4%+46.8% a yearPrice +216.4%+43.1%+12.7% a yearPrice +30.5%
5 years since November 18, 2021+8.7%+1.7% a yearPrice +8.7%+86.3%+13.2% a yearPrice +59.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ESTAEstablishment LabsMRKMerck & Company

Valuation

ESTAMRK
Valuation
Price$69.61$132.81
Market value$2.0B$328B
Enterprise value (EV)–$372B
P/E–133.9
P/E, 5-year median–14.8
P/B130.97.3
EV/EBIT–78.2
Free cash flow yield–4.5%

Results and growth

ESTAMRK
Results and growth
Revenue, 12 months$264M$67.4B
Net income, 12 months-$38M$2.5B
Free cash flow, 12 months-$22M$14.7B
Earnings per share, 12 months-$1.27$0.98
Revenue growth, year on year27.1%1.3%
Revenue growth a year, past+20.0%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

ESTAMRK
Margins and returns on capital
Gross margin70.2%71.8%
Operating margin-6.6%–
Net margin-14.6%3.6%
ROIC-5.0%3.9%
ROE-209.2%5.2%

Balance sheet

ESTAMRK
Balance sheet
Cash$76M$9.7B
Total debt–$53.8B
Net debt / EBITDA–5.7
Interest cover-0.6×2.4×

Dividends and buybacks

ESTAMRK
Dividends and buybacks
Dividend yield–2.6%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.6%
Shareholder yield–4.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ESTA or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Establishment Labs or Merck & Company?

By market value, Merck & Company ($328B) is about 160.9 times Establishment Labs ($2.0B), at today's prices.

How did ESTA and MRK stock do over the last 5 years?

Since November 18, 2021, ESTA's price moved +8.7% and MRK's +59.9%. With dividends: ESTA +8.7% (+1.7% a year), MRK +86.3% (+13.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, ESTA or MRK?

The dividend yield at today's price is none for Establishment Labs and 2.56% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

Which has the higher profit margins, Establishment Labs or Merck & Company?

Over the last twelve months, the net margin was -14.6% for Establishment Labs and 3.6% for Merck & Company, and the operating margin -6.6% and –. Revenue was $264M and $67.4B.

Which is the better investment, Establishment Labs or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.